Correction to: Nature Communications https://doi.org/10.1038/s41467-023-40057-8, published online 19 July 2023
The original version of this Article contained an error in Fig. 3b, in which amino acid frequencies at positions 64, 68 and 208 for the ‘Phase 2b’ trial, and at position 204 for the ‘MELODY’ trial were incorrect. The correct version of Fig. 3 is:
which replaces the previous incorrect version:
This has been corrected in both the PDF and HTML versions of the Article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ahani, B., Tuffy, K.M., Aksyuk, A.A. et al. Author Correction: Molecular and phenotypic characteristics of RSV infections in infants during two nirsevimab randomized clinical trials. Nat Commun 15, 3026 (2024). https://doi.org/10.1038/s41467-024-47421-2
Published:
DOI: https://doi.org/10.1038/s41467-024-47421-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
